Oracle (ORCL) Stock Forecast & Price Target

$280.08 +7.43 (+2.72%)

Closing price 10/23/2025 03:59 PM Eastern

Extended Trading

$285.15 +5.06 (+1.81%)

As of 09:23 AM Eastern

Compare

Oracle - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Moderate Buy

Based on 41 Analyst Ratings

Sell
2

Hold
9

Buy
30

Based on 41 Wall Street analysts who have issued ratings for Oracle in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 41 analysts, 2 have given a sell rating, 9 have given a hold rating, 27 have given a buy rating, and 3 have given a strong buy rating for ORCL.

Consensus Price Target

$323.69
15.57% Upside

According to the 41 analysts' twelve-month price targets for Oracle, the average price target is $323.69. The highest price target for ORCL is $410.00, while the lowest price target for ORCL is $130.00. The average price target represents a forecasted upside of 15.57% from the current price of $280.09.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for ORCL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Oracle and its competitors.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ORCL Analyst Ratings Over Time

Type	Current Forecast 10/24/24 to 10/24/25	1 Month Ago 9/24/24 to 9/24/25	3 Months Ago 7/26/24 to 7/26/25	1 Year Ago 10/25/23 to 10/24/24
Strong Buy	3 Strong Buy rating(s)	2 Strong Buy rating(s)	3 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	27 Buy rating(s)	25 Buy rating(s)	23 Buy rating(s)	19 Buy rating(s)
Hold	9 Hold rating(s)	9 Hold rating(s)	8 Hold rating(s)	11 Hold rating(s)
Sell	2 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$323.69	$305.75	$218.29	$168.52
Forecasted Upside	15.57% Upside	-1.01% Downside	-10.92% Downside	-3.36% Downside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

ORCL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ORCL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Oracle Stock vs. The Competition

Type	Oracle	Computer and Technology Companies	S&P 500
Consensus Rating Score	2.76	2.31	2.52
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	15.57% Upside	58.84% Upside	12.13% Upside
News Sentiment Rating	Positive News See Recent ORCL News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
10/20/2025	The Goldman Sachs Group 3 of 5 stars	Kash Rangan 1 of 5 stars	Reiterated Rating	Neutral	$320.00	+9.61%
10/17/2025	Scotiabank 4 of 5 stars	Patrick Colville Not Rated	Boost Target	Outperform	$350.00 ➝ $360.00	+23.35%
10/17/2025	Cowen 1 of 5 stars		Reiterated Rating	Buy
10/17/2025	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kirk Materne Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$350.00 ➝ $385.00	+30.18%
10/17/2025	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brent Bracelin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$330.00 ➝ $380.00	+21.59%
10/17/2025	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Karl Keirstead Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$360.00 ➝ $380.00	+21.59%
10/17/2025	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raimo Lenschow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$367.00 ➝ $400.00	+27.99%
10/17/2025	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brent Thill Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$360.00 ➝ $400.00	+27.99%
10/17/2025	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform
10/17/2025	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rishi Jaluria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Sector Perform	$310.00	+5.20%
Get the Latest News and Ratings for ORCL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Oracle and its competitors with MarketBeat's FREE daily newsletter.
10/17/2025	JMP Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Market Outperform	$342.00	+14.34%
10/17/2025	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brett Huff Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Equal Weight	$208.00 ➝ $331.00	+5.91%
10/17/2025	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Difucci Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$375.00 ➝ $400.00	+27.99%
10/13/2025	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Bachman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target	Outperform	$345.00 ➝ $355.00	+21.14%
10/10/2025	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tyler Radke Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy
10/8/2025	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rob Oliver Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Outperform	$365.00	+26.53%
10/8/2025	Baird R W Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Strong-Buy
10/8/2025	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Hold (C+) ➝ Buy (B-)
9/26/2025	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark L. Moerdler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$363.00 ➝ $364.00	+27.28%
9/25/2025	Redburn Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alex Haissl Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$175.00	-41.03%
9/25/2025	Rothschild Redb Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Strong Sell
9/25/2025	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alex Haissl Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Sell	$175.00	-43.34%
9/23/2025	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Weiss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Equal Weight	$246.00 ➝ $320.00	+1.73%
9/15/2025	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nay Soe Naing Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Hold	$202.00 ➝ $306.00	+1.24%
9/10/2025	BNP Paribas Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$377.00	+14.80%
9/10/2025	Melius Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Reitzes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$270.00 ➝ $370.00	+11.29%
9/10/2025	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Derrick Wood Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$325.00 ➝ $375.00	+11.18%
9/10/2025	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Blakey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$271.00 ➝ $400.00	+65.51%
9/10/2025	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Siti Panigrahi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$300.00 ➝ $350.00	+44.83%
9/10/2025	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Reback Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$250.00 ➝ $350.00	+44.83%
9/10/2025	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Sills Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$295.00 ➝ $368.00	+52.27%
9/10/2025	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alex Zukin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$300.00 ➝ $400.00	+65.51%
9/10/2025	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gil Luria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$220.00 ➝ $300.00	+24.14%
9/8/2025	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Murphy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$185.00 ➝ $210.00	-12.09%
6/18/2025	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Hold
6/18/2025	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform
6/18/2025	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Strong-Buy
6/12/2025	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Zelnick Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$200.00 ➝ $240.00	+36.11%
6/12/2025	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jackson Ader Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$200.00 ➝ $225.00	+27.60%
6/12/2025	Westpark Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	C. Shauger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$195.00 ➝ $246.00	+39.51%

6/10/2025	Loop Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Murphy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$135.00	-23.99%
6/9/2025	CIBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy
3/3/2025	Monness Crespi & Hardt Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	B. White Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Sell ➝ Neutral
9/16/2024	Melius Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Hold ➝ Buy	$210.00	+29.61%
6/18/2024	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Buy	$145.00 ➝ $159.00	+11.83%
3/13/2024	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Buy	$144.00 ➝ $155.00	+21.42%
12/22/2023	Erste Group Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy ➝ Hold
11/13/2023	Edward Jones Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Hold ➝ Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 09:18 AM ET.

Should I Buy Oracle Stock? ORCL Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, October 22, 2025. Please send any questions or comments about these Oracle pros and cons to contact@marketbeat.com.

Oracle
Bull Case

Here are some ways that investors could benefit from investing in Oracle:

Oracle has received multiple upgrades from analysts, with price targets significantly raised, indicating strong market confidence in the company's future performance.
The current stock price is around $275, which is near the lower end of its 12-month range, suggesting potential for growth as the market stabilizes.
With a market capitalization of approximately $784 billion, Oracle is positioned as a major player in the tech industry, providing stability and growth potential for investors.
Analysts have rated Oracle with a consensus of "Moderate Buy," reflecting a generally positive outlook among market experts.
Recent insider trading activity shows executives selling shares at high prices, which may indicate confidence in the company's valuation and future prospects.

Oracle
Bear Case

Investors should be bearish about investing in Oracle for these reasons:

Despite positive ratings, there are still two analysts who have assigned a "Sell" rating, indicating some skepticism about the stock's future performance.
The company's high debt-to-equity ratio of 3.33 suggests that Oracle is heavily leveraged, which could pose risks in a rising interest rate environment.
Insider selling has been significant, with over 120,000 shares sold recently, which may raise concerns about the executives' confidence in the company's short-term performance.
Oracle's price-to-earnings ratio of 63.69 is relatively high, which could indicate that the stock is overvalued compared to its earnings, making it a riskier investment.
The stock has shown volatility, with a 12-month high of $345.72 and a low of $118.86, which may deter risk-averse investors.

ORCL Forecast - Frequently Asked Questions

: According to the research reports of 41 Wall Street equities research analysts, the average twelve-month stock price forecast for Oracle is $323.69, with a high forecast of $410.00 and a low forecast of $130.00.
: 41 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Oracle in the last twelve months. There are currently 2 sell ratings, 9 hold ratings, 27 buy ratings and 3 strong buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" ORCL shares.
: According to analysts, Oracle's stock has a predicted upside of 15.57% based on their 12-month stock forecasts.
: Over the previous 90 days, Oracle's stock had 5 upgrades by analysts.
: Oracle has been rated by research analysts at Baird R W, Bank of America, Barclays, Berenberg Bank, BMO Capital Markets, BNP Paribas, Cantor Fitzgerald, Citigroup, Cowen, DA Davidson, Evercore ISI, Guggenheim, Jefferies Financial Group, JMP Securities, JPMorgan Chase & Co., Melius Research, Mizuho, Morgan Stanley, Piper Sandler, Redburn Partners, Robert W. Baird, Rothschild & Co Redburn, Rothschild Redb, Royal Bank Of Canada, Sanford C. Bernstein, Scotiabank, Stephens, Stifel Nicolaus, TD Cowen, The Goldman Sachs Group, UBS Group, Weiss Ratings, William Blair, and Wolfe Research in the past 90 days.
: Analysts like Oracle more than other "computer and technology" companies. The consensus rating for Oracle is Moderate Buy while the average consensus rating for "computer and technology" companies is Hold. Learn more on how ORCL compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:ORCL) was last updated on 10/24/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Oracle (ORCL) Stock Forecast & Price Target

Oracle - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Consensus Price Target

ORCL Analyst Ratings Over Time

ORCL Analyst Recommendations By Month

ORCL Price Targets by Month

Oracle Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Oracle Stock? ORCL Pros and Cons Explained

Oracle
Bull Case

Oracle
Bear Case

ORCL Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Oracle (ORCL) Stock Forecast & Price Target

Oracle - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Consensus Price Target

ORCL Analyst Ratings Over Time

ORCL Analyst Recommendations By Month

ORCL Price Targets by Month

Oracle Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Oracle Stock? ORCL Pros and Cons Explained

Oracle Bull Case

Oracle Bear Case

ORCL Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

Oracle
Bull Case

Oracle
Bear Case